Fertility preservation is the process of freezing the eggs (oocytes), sperm, embryos or reproductive tissue so that a person can use them to hopefully has their own biological children in the future. Preservation of fertility is possible for men and women.
Ovarian tissue may also be used to prevent infertility, as well as birth defects, associated with advanced maternal age. Advances in medical expertise and technology have provided us with more options than ever to help preserve our patients’ fertility.
Fertility preservation is a sub-specialty within the field of reproductive endocrinology and infertility, which focuses on helping reproductive-age men and women who are facing cancer treatment and understanding their risks of infertility and possible treatment options.
We understand that survival is the primary consideration as the patients get ready to undergo chemotherapy. The Fertility Preservation Program provide information regarding his or her risk of decreased fertility potential after cancer treatment. Chemotherapy or radiation can damage sperm and eggs, but the degree of damage is often hard to predict. For women, one marker of decreased fertility potential after cancer treatment is the loss of menstrual cycles, or the premature menopause. However, some women who still have menstrual cycles after their cancer treatments may have the diminished ovarian reserve. Patients with diminished ovarian reserve may have complexity in conceiving. For men, either the cancer itself or the cancer treatments can causes the infertility problem. Specific cancers that can damages the testes include the testicular cancer and Hodgkin’s Lymphoma.
Factors that may play a role in future infertility include:
Gender
we are having a robust vitrification program and our outcome in frozen cycle is as good as compared to best in the world .
To more about our fertility preservation program pl contact our fertility specialists.
Fertility preservation is the process of freezing the eggs (oocytes), sperm, embryos or reproductive tissue so that a person can use them to hopefully has their own biological children in the future. Preservation of fertility is possible for men and women.
Ovarian tissue may also be used to prevent infertility, as well as birth defects, associated with advanced maternal age. Advances in medical expertise and technology have provided us with more options than ever to help preserve our patients’ fertility.
Fertility preservation is a sub-specialty within the field of reproductive endocrinology and infertility, which focuses on helping reproductive-age men and women who are facing cancer treatment and understanding their risks of infertility and possible treatment options.
We understand that survival is the primary consideration as the patients get ready to undergo chemotherapy. The Fertility Preservation Program provide information regarding his or her risk of decreased fertility potential after cancer treatment.
Chemotherapy or radiation can damage sperm and eggs, but the degree of damage is often hard to predict. For women, one marker of decreased fertility potential after cancer treatment is the loss of menstrual cycles, or the premature menopause.
However, some women who still have menstrual cycles after their cancer treatments may have the diminished ovarian reserve. Patients with diminished ovarian reserve may have complexity in conceiving.
For men, either the cancer itself or the cancer treatments can causes the infertility problem. Specific cancers that can damages the testes include the testicular cancer and Hodgkin’s Lymphoma.
we are having a robust vitrification program and our outcome in frozen cycle is as good as compared to best in the world .
To more about our fertility preservation program pl contact our fertility specialists.